Also trades as: HSCL.BO (BSE) · $vol 3M
HSCL.NS NSE
Himadri Speciality Chemical Limited
1W: -1.4%
1M: -2.3%
3M: -2.3%
YTD: +44.4%
1Y: +42.5%
3Y: +233.2%
5Y: +1349.1%
₹661.10 ($6.87)
-16.70 (-2.46%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$46.6B
+1.0% ▲
5Y CAGR: +22.6%
Gross Profit
$15.0B
+4.7% ▲
5Y CAGR: +28.8%
Operating Income
$9.3B
-24.1% ▼
5Y CAGR: +22.6%
Net Income
$7.5B
+35.2% ▲
5Y CAGR: +73.7%
EPS (Diluted)
$15.02
+34.5% ▲
5Y CAGR: +67.8%
EBITDA
$11.3B
+34.5% ▲
5Y CAGR: +54.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $27.9B | $41.7B | $41.8B | $46.1B | $46.6B |
| YoY Growth | +66.2% | +49.5% | +0.3% | +10.2% | +1.0% |
| Cost of Revenue | $22.8B | $33.0B | $30.7B | $31.8B | $31.6B |
| Gross Profit | $5.1B | $8.8B | $11.2B | $14.3B | $15.0B |
| Gross Margin | 18.3% | 21.0% | 26.7% | 31.1% | 32.2% |
| R&D Expenses | $59M | $307M | $321M | $359M | $0 |
| SG&A Expenses | $842M | $970M | $1.3B | $1.7B | $5.7B |
| Operating Expenses | $900M | $1.3B | $1.6B | $2.0B | $5.7B |
| Operating Income | $4.2B | $7.5B | $9.6B | $12.3B | $9.3B |
| Operating Margin | 15.1% | 17.9% | 22.9% | 26.7% | 20.0% |
| Interest Expense | $334M | $526M | $608M | $427M | $644M |
| Income Before Tax | $535M | $2.8B | $5.7B | $8.1B | $10.0B |
| Tax Expense | $144M | $644M | $1.6B | $2.5B | $2.5B |
| Net Income | $409M | $2.2B | $4.1B | $5.6B | $7.5B |
| Net Margin | 1.5% | 5.2% | 9.8% | 12.0% | 16.1% |
| EPS (Diluted) | $0.98 | $5.13 | $9.16 | $11.17 | $15.02 |
| EBITDA | $1.6B | $4.1B | $6.3B | $8.4B | $11.3B |
| Shares Outstanding | 419M | 421M | 449M | 497M | 500M |